Артериальная гипертензия

Расширенный поиск

Недостаточная приверженность к лечению артериальной гипертензии: причины и пути коррекции

Полный текст:

Об авторах

А. О. Конради
НИИ кардиологии им. В.А. Алмазова МЗ и СР РФ

Е. В. Полуничева
НИИ кардиологии им. В.А. Алмазова МЗ и СР РФ

Список литературы

1. Hill M., Houston N. Adherence to antihypertensive therapy. Chapter 131: 390-2.

2. Waeber B., Bumier M., Brunner H.R. How to improve adherence with presaibed treatment in hypertensive patients? J Cardiovasc Pharmacol 2000: 36 (suppl. 3): S23 -S26.

3. Haynes R.B., McKibbon K.A., Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383-6.

4. Maronde R.F., Chan L.S., Larcen F.J. et atl. Underrutilization of antihypertensive drugs and associated hospitalization. Med Care 1989; 27: 1159-66.

5. Combs J.S., Nichol M.B., Newman C.M., Sclar D.A. The costs of interrupting antihypertensive drag therapy' n a Medicaid population. Med Care 1994; 32: 214-26.

6. Horvathora H., Kimlikova K., Balazovjech I., Kyselovic I. Compliance and the therapeutic effect in patients with arterial hypertension. Bratist Lek Listy 2003. 104 (4-5): 149-54.

7. Vander Stichele. Measurement of patient compliance and the interpretation of randomized trials. Eur J Clin Pharmacol. 1991: 41: 27-35.

8. Labdenpera T.S., Wright C.C., Kyngas H.A. Development of a scale to assess the compliance of hypertensive patients. Int J Nurs Stud 2003 Sep: 40 (7): 677-84.

9. Morisky D.E., Chan L.S., Larsen F.J. Concurrent and predictive validity of self-reported measure of medical adherence. Med Care 1986: 24: 67-73.

10. Strelec M.A., Mion A.M. The influence of patient's consciousness regarding high blood pressure and patient's attitude in face of disease controlling medicine intake. Arc Bras Cardiol 2003: 81: 349-54.

11. Port K., Palm K., Viigimaa M. Self-reported compliance of patients leeching antihypertensive treatment: use of a telemonitoring home care system. J Telemed Telecare 2003. 9 (Suppl. 1): S65-6.

12. Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood pressure 2001: 10: 62-73.

13. Hamilton G.A. Measuring adherence in a hypertension clinical trial. J Manag Care Pharm: 9 (5): 424-9.

14. The major outcomes in high-risk hypertensive patients randomized to angiotensin -converting enzyme inhibitor or calcium channel blocker vs diuretic. ALLHAT. JAMA 2002: 288: 2981-97.

15. Murlow P.J. Detection and control of hypertinsion in the population: the t United States Experience. Am J Hypertens 1998; 11: 744-6.

16. Hoste J., Wiklund I. Managing hypertension in general practice: can ire do better? J Hum Hypertens 1995: 9: S15-S18.

17. Mashru M., Lant A. Interpractice audit of diagnosis and management if hypertension in primary care: educational intervention and review of medical records. BMJ 1997; 314: 942-6.

18. Neutel J., Smith D. Improving patient compliance: a major goal in /he management of hypertension. J Clin Hypertens 2003; 5: 127-32.

19. Эйдельман С.Е. Фармакоэпидемиология артериальной гипертензии в Петроградском районе Санкт-Петербурга. Артериальная гипертензия 2003; 9.

20. Moser M. Clinical management of hypertension. 6th ed.Caddo professional communications. Ins.: 2002.

21. Birtwistle R.V., Godwin M.S., Delva M.D. et al. Randomized equivalence trial comparing three mouth and six month follow up of patients with hypertension by family practitioners. BMJ. doi: 10.1 l36/bmj37967374063.EE (January 2004).

22. Menard J., Chatellier G., I. Lifting factors in the control of blood pressure: why is there a gap between theory and practice? J Hum Hypertens 1995: 9 (suppl. 2): 19-23.

23. Fletcher A. Quality of life in the management of hypertension. Clin Exp Hypertens 1999; 21: 961 -72.

24. Wallenius S.H., Vainio K.K., Korhonen M.J. et al. Self-initialed modification of hypertension treatment in response to perceived problems.Ann Pharmacother 1995: 29: 1213-7.

25. Lip G.Y., Beevers G.D. Doctors, nurses, pharmacists and patients. The rational evaluation and choice in hypertension (REACH) surrey of hypertension delivery. Blood Pressure 1997; 6: 6-11.

26. Benson J., Britten N. Keep taking the tablets. BMJ 2003; 327: l-6.

27. Townsend A., Hunt K., Wuke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ 2003: 327: 1-6.

28. Конради A.О., Соболева А.В., Максимова Т.А. и др. Обучение больных гипертоническое болезнью - бессмысленная трата времени или реальный инструмент к повышении качества контроля заболевания? Артериал. гипертензия.

29. Jokasalo E., Entund H., Halonen P. et al. Factors related to poor control of blood pressure with antihypertensive therapy. Blood Pressure 2002: 12: 22-7.

30. Prochaska J.O., Reddoug C.A., Evers K.E. The Transtheoretical Model and Stages of Change. In: Glanz К. editor. Health behavior and health education: theory, research, and practice. 2nd edn.San Francisco; Jossey Bass. 1997.

31. Benson J., Britten N. Patients decisions about Whether or not to take antihypertensive drugs: qualitative study. BMJ 2002; 325: 873.

32. Monane M., Bohn R.L., Gurwitz H.T. et a. The effects of initial drug choice and со morbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997: 10: 697-704.

33. Mancia G., Seravalle G., Grassi G. Tolerability and treatment compliance with angiotensin II receptor antagonists. Am J Hypertens 2003; 16 (12): 1066-73.

34. Wogen J., Kreilick C.A., Livornese R.C. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm 2003; 9 (5): 424-9.

35. Toyoshima H., Takahashi K., Akera T. The impact of side effects on hypertension management. A Japanese survey. Clin Ther 1997; 19: 1458-69.

36. Lee J.Y., Kusek J.W., Greene P.G. et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1990: 9: 719-25.

37. Waeber B., Erne P. Saxenhofer H. et al. Use of drugs with more than 24-hour duration of action. J Hypertens 1994: 12 (Suppl. 8):67-71.

38. Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.

39. Caro J.J., Speckman J.L., Salas M. et al. Effect of initial choice on persistence with antihypertensive therapy: the importance of actual practice data CMAJ 1999: 160: 41-6.

40. Waeher B., Brunner H.R., Metry J.M. Compliance with antihypertensive treatment: implication to practice. Blood Pressure 1997: 6: 326-31.

41. Eraker S.A., Karscht J.P., Becker M.N. Understanding and improving patients compliance. Ann Int Med 1984; 100: 258-68.

42. Caro J.J. Stepped care for hypertension: are the assumption: are the assumption? J Hypertens 1997; 15 (Suppl. 7): 35-9.

43. Kjellgren K.T., Svensson S., Ahluer J., Saljo R. Hypertensive patients knowledge of high blood pressure. Scand J Prim Health Care 1997 Dec: 15 (4): 188-92.

44. Gruesser M., Hartmann P., Schlottmann N., Lohmann F.W., Sawicki P.T., Joergens V. Structured patient education for out-patients with hypertension in general practice: a model project in Germany. J Hum Hypertens 1997 Aug: 11 (8): 501-6.

45. Cuspidi C., Sampieri L., Macca G. et al. Improvement if patients knowledge by a single educational meeting on hypertension. J Hum Hypertens 2001 Jan: 15 (1): 57-61.

46. Zernike W., Henderson A., Evalualing the effectiveness of two leaching strategies for patients diagnosed with hypertension. J Clin Nurs 1998 Jan: 7 (1): 37-44.

47. Cuspidi C., Lonati L. Sampieri L. et al. To better know hypertension: educational meetings for hypertensive patients. Blood Pressure 2000; 9: 255-9.

48. Filippi A., Sahatini A., Badioli L. Effects of an automated electronic reminder in changing the antiplatelel drug-prescribing behavior among Italian general practitioners in diabetic patients: an intervention trial. Diabetes Care. 2003 May: 26 (5): 1497-500.

49. Frerdman R.H., Kazis L.E., Jette A. et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996: 9: 285-92.

50. Haynes B.R., Sackett D.L., Gibson E.S. et al. Improvement if medical compliance in uncontrolled hypertension. Lancet 1976: i: 1265-8.

51. Vrijens B., Gioethebeur E. Comparing compliance patterns between randomized treatments. Controlled clinical trials 1997; 18: 187-203.

52. Bloom B.S. Continuation of initial antihypertensive medication after I year of therapy. Clin Ther 1998; 20: 1-11.

53. Rudd P. Clinicians and patients with hypertension: Unsettled issues about compliance. Am Heart J 1995: 130: 572-89.

54. Sackett D.L., Haynes R.B., Gibson E.S. et al. Randomized clinical trial if strategies for improving medication compliance in primary hypertension. Lancet 1975; 1: 1205-7.

55. Центральная, периферическая и почечная гемодинамика у больных гипертонической болезнью на фоне длительной монотерапии эналаприлом и комбинации с гидрохлортиазидом (по данным исследования RU-003). Артериальная гипертензия 2004: 10: 19-22.

Для цитирования:

Конради А.О., Полуничева Е.В. Недостаточная приверженность к лечению артериальной гипертензии: причины и пути коррекции. Артериальная гипертензия. 2004;10(3):137-143.

For citation:

Konradi A.O., Polunicheva Y.V. Inadequate compliance in the treatment of arterial hypertension: causes and ways of correction. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2004;10(3):137-143. (In Russ.)

Просмотров: 163

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)